Augmented Accumbal Serotonin Levels Decrease the Preference for a Morphine Associated Environment During Withdrawal
by
Harris GC, Aston-Jones G
University of Pennsylvania,
VAMC 151 Rm A520,
University and Woodland Ave,
19104, Philadephia, PA, USA
Neuropsychopharmacology 2001 Jan 1; 24(1):75-85

ABSTRACT

Recent studies have found that acute morphine administration increases serotonin (5-HT) transmission within the nucleus accumbens and other forebrain regions. In contrast, 5-HT transmission is depressed during withdrawal from chronic morphine. We show that pharmacological agents that increase brain 5-HT levels (fluoxetine or 5-hydoxytryptophan, 5-HTP) abolish the preference of chronically morphine-treated, withdrawn rats for a morphine-associated environment. Similar results were seen when fluoxetine was microinjected into the nucleus accumbens. Conversely, rats given morphine acutely showed an enhanced preference for a morphine-associated environment when pretreated with these agents. Fluoxetine also decreased the heightened anxiety found in morphine withdrawn rats. The results of our study indicate that drugs that augment 5-HT levels may reduce the desire for morphine during withdrawal.

Mu
Pain
Heroin
Morphine
Tolerance
Endomorphins
Intravenous rush
Kadian v MS Contin
Morphine: structure
Fentanyl and ketamine
Is morphine a smart drug?
Opioids, mood and cognition
Is morphine an antidepressant?
Methadone, morphine and heroin
Tolerance, sensitization and dependence
Opioids, depression and learned helplessness

Refs
HOME
HedWeb
Cannabis.net
BLTC Research
Designer Drugs
Paradise-Engineering
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?